No Data
No Data
Earnings Preview: IONS to Report Financial Results on April 30
Press Release: Ionis to Hold First Quarter 2025 Financial Results Webcast
Express News | Ionis Pharmaceuticals Inc : Leerink Partners Cuts Target Price to $54 From $55
H.C. Wainwright Maintains Ionis Pharmaceuticals(IONS.US) With Buy Rating, Maintains Target Price $45
TD Cowen Maintains Ionis Pharmaceuticals(IONS.US) With Buy Rating, Maintains Target Price $59
Trending Stocks Today | ICAD Inc Soars 74.61% Post-Market